Clevenbergh P - Search Results

1

Hepatitis B or hepatitis C virus infection is a risk factor for severe hepatic cytolysis after initiation of a protease inhibitor-containing antiretroviral regimen in human immunodeficiency virus-infected patients. The APROCO Study Group.

Savès M, Raffi F, Clevenbergh P, Marchou B, Waldner-Combernoux A, Morlat P, Le Moing V, Rivière C, Chêne G, Leport C. Savès M, et al. Among authors: clevenbergh p. Antimicrob Agents Chemother. 2000 Dec;44(12):3451-5. doi: 10.1128/AAC.44.12.3451-3455.2000. Antimicrob Agents Chemother. 2000. PMID: 11083658 Free PMC article.

2

Importance of protease inhibitor plasma levels in HIV-infected patients treated with genotypic-guided therapy: pharmacological data from the Viradapt Study.

Durant J, Clevenbergh P, Garraffo R, Halfon P, Icard S, Del Giudice P, Montagne N, Schapiro JM, Dellamonica P. Durant J, et al. Among authors: clevenbergh p. AIDS. 2000 Jul 7;14(10):1333-9. doi: 10.1097/00002030-200007070-00005. AIDS. 2000. PMID: 10930147 Clinical Trial.

3

Early CD4(+) T cell recovery in human immunodeficiency virus-infected patients receiving effective therapy is related to a down-regulation of apoptosis and not to proliferation.

Roger PM, Breittmayer JP, Durant J, Sanderson F, Ceppi C, Brignone C, Cua E, Clevenbergh P, Fuzibet JG, Pesce A, Bernard A, Dellamonica P; Groupe d'Etudes Niçois Polyvalent en Infectiologie. Roger PM, et al. Among authors: clevenbergh p. J Infect Dis. 2002 Feb 15;185(4):463-70. doi: 10.1086/338573. Epub 2002 Jan 31. J Infect Dis. 2002. PMID: 11865398

4

Opportunistic diseases in HIV-infected patients in Gabon following the administration of highly active antiretroviral therapy: a retrospective study.

Okome-Nkoumou M, Guiyedi V, Ondounda M, Efire N, Clevenbergh P, Dibo M, Dzeing-Ella A. Okome-Nkoumou M, et al. Among authors: clevenbergh p. Am J Trop Med Hyg. 2014 Feb;90(2):211-5. doi: 10.4269/ajtmh.12-0780. Epub 2013 Dec 9. Am J Trop Med Hyg. 2014. PMID: 24323514 Free PMC article.

5

Persisting long-term benefit of genotype-guided treatment for HIV-infected patients failing HAART. The Viradapt Study: week 48 follow-up.

Clevenbergh P, Durant J, Halfon P, del Giudice P, Mondain V, Montagne N, Schapiro JM, Boucher CA, Dellamonica P. Clevenbergh P, et al. Antivir Ther. 2000 Mar;5(1):65-70. Antivir Ther. 2000. PMID: 10846595 Clinical Trial.

6

Efficacy, safety and predictive factors of virological success of a boosted amprenavir-based salvage regimen in heavily antiretroviral-experienced HIV-1-infected patients.

Clevenbergh P, Boulmé R, Kirstetter M, Dellamonica P. Clevenbergh P, et al. HIV Med. 2004 Jul;5(4):284-8. doi: 10.1111/j.1468-1293.2004.00222.x. HIV Med. 2004. PMID: 15236618 Free article. Clinical Trial.

7

Fatal interruption of a 3TC-containing regimen in a HIV-infected patient due to re-activation of chronic hepatitis B virus infection.

Sellier P, Clevenbergh P, Mazeron MC, Cazals-Hatem D, Evans J, Cervoni J, Badsi E, Bendenoun M, Diemer M, Vincent V, Caulin C, Bergmann JF. Sellier P, et al. Among authors: clevenbergh p. Scand J Infect Dis. 2004;36(6-7):533-5. doi: 10.1080/00364450410015925. Scand J Infect Dis. 2004. PMID: 15307596 No abstract available.

8

Improving HIV infection management using antiretroviral plasma drug levels monitoring: a clinician's point of view.

Clevenbergh P, Mouly S, Sellier P, Badsi E, Cervoni J, Vincent V, Trout H, Bergmann JF. Clevenbergh P, et al. Curr HIV Res. 2004 Oct;2(4):309-21. doi: 10.2174/1570162043351129. Curr HIV Res. 2004. PMID: 15544452 Review.

9

Impact of various antiretroviral drugs and their plasma concentrations on plasma lipids in heavily pretreated HIV-infected patients.

Clevenbergh P, Garraffo R, Dellamonica P. Clevenbergh P, et al. HIV Clin Trials. 2003 Sep-Oct;4(5):330-6. doi: 10.1310/8TXF-P814-8JPF-7TRY. HIV Clin Trials. 2003. PMID: 14583849

10

Intracellular concentration of protease inhibitors in HIV-1-infected patients: correlation with MDR-1 gene expression and low dose of ritonavir.

Chaillou S, Durant J, Garraffo R, Georgenthum E, Roptin C, Clevenbergh P, Dunais B, Mondain V, Roger PM, Dellamonica P. Chaillou S, et al. Among authors: clevenbergh p. HIV Clin Trials. 2002 Nov-Dec;3(6):493-501. doi: 10.1310/0873-bvdp-akay-445u. HIV Clin Trials. 2002. PMID: 12501133

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

86 results

Search Page